Testing the Addition of Duvelisib or CC-486 to the Usual Treatment for Peripheral T-Cell Lymphoma
Alliance for Clinical Trials in Oncology
Alliance for Clinical Trials in Oncology
Dana-Farber Cancer Institute
City of Hope Medical Center
City of Hope Medical Center
University of Nebraska
University of Washington
City of Hope Medical Center